NorthCrest Asset Manangement’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$969K Buy
12,638
+709
+6% +$60.3K 0.02% 387
2026
Q1
$1.05M Buy
11,929
+1,511
+15% +$136K 0.03% 321
2025
Q4
$943K Buy
10,418
+334
+3% +$25.4K 0.02% 393
2025
Q3
$598K Buy
10,084
+3,237
+47% +$186K 0.01% 451
2025
Q2
$405K Sell
6,847
-3,800
-36% -$246K 0.01% 459
2025
Q1
$779K Sell
10,647
-3
-0% -$248 0.02% 342
2024
Q4
$881K Buy
10,650
+3
+0% +$237 0.03% 312
2024
Q3
$762K Buy
10,647
+50
+0.5% +$3.53K 0.02% 335
2024
Q2
$726K Hold
10,597
0.02% 317
2024
Q1
$568K Sell
10,597
-187
-2% -$10.1K 0.02% 361
2023
Q4
$575K Hold
10,784
0.02% 354
2023
Q3
$535K Buy
+10,784
New +$603K 0.02% 351

Other funds holding GMED

NorthCrest Asset Manangement's GMED Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Globus Medical (GMED) stake by 5.9% in Q2 2026, buying an estimated $60.3K and bringing the position to 12,638 shares worth $969K. The position accounts for 0.02% of the portfolio, ranked #387.

NorthCrest Asset Manangement first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • NorthCrest Asset Manangement held 12,638 shares of Globus Medical worth $969K as of Q2 2026.
  • NorthCrest Asset Manangement bought 709 Globus Medical shares in Q2 2026, an estimated $60.3K.
  • Globus Medical made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #387 holding.
  • NorthCrest Asset Manangement first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • NorthCrest Asset Manangement's Globus Medical position peaked at $1.05M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.